Isolated Posterior Cerebral Artery Infarction Caused by Carotid Artery Dissection
Arch Neurol 66:1034-1035, de H. Christoph,D.,et al, 2009
Pardoxical Facilitation: The Resolution of Foreign Accent Syndrome After Cerebellar Stroke
Neurol 73:566-567, Cohen,D.A.,et al, 2009
Who Is Ineligible for Warfarin in Atrial Fibrillation?
Lancet 374:510-511, Verheugt,F.W.A., 2009
Nail-Gun Narcolepsy
Lancet 374:238, Mokhlesi,B &Khan,M., 2009
Clinicopath Conf., Atypical Hemolytic-Uremic Syndrome
NEJM 361:389-400, Case 23-2009, 2009
Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009
Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009
Facial Pain
The Neurologist 15:171-177, Graff-Radford,S.B., 2009
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Stroke 40:2349-2355, Alsheikh-Ali,A.A.,et al, 2009
Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009
Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009
Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009
Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009
Influence of Weekend Hospital Admission on Short-Term Mortality After Intracerebral Hemorrhage
Stroke 40:2387-2392, Crowley,R.W.,et al, 2009
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009
Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009
Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009
A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care: A Scientific Statement from the American Heart Association/American Stroke Association
Stroke 40:2616-2634, Schwamm,L.H.,et al, 2009
Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care: A Policy Statement From the American Heart Association
Stroke 40:2635-2660, Schwamm,L.H.,et al, 2009
Urgency of Carotid Endarterectomy for Secondary Stroke Prevention: Results from the Registry of the Canadian Stroke Network
Stroke 40:2776-2782, Gladstone,D.J.,et al, 2009
Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009
MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009
Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
AJNR 30:1371-1379, Hefzy,H.M.,et al, 2009
Distal Hyperintense Vessels on FLAIR: An MRI Marker for Collateral Circulation in Acute Stroke?
Neurol 72:1134-1139, Lee,K.Y.,et al, 2009
The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009
Stroke in Women: An Evolving Topic
Stroke 40:1027-1028, Kurth,T. &Bousser,M.-G., 2009
Sex Differences in Stroke Epidemiology: A Systematic Review
Stroke 40:1082-1090, Appelros,P.,et al, 2009
Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009
Slurred Speech and Spirochaetes
Lancet 373:978, Thukral,A.,et al, 2009
Carbon Monoxide Poisoning
NEJM 360:1217-1225, Weaver,L.K., 2009
Diagnostic Value of Spinal MR Imaging in Spontaneous Intracranial Hypotension Syndrome
AJNR 30:147-151, Watanabe,A.,et al, 2009
The Relationship Between Baseline Blood Pressure and Computed Tomography Findings in Acute Stroke: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
Stroke 40:41-46, Sare,G.M.,et al, 2009
Use of MRI to Estimate the Therapeutic Window in Acute Stroke: Is Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch an EPITHET for Salvageable Ischemic Brain Tissue?
Stroke 40:333-335, Toth,G. &Albers,G.W., 2009
Stroke Unit Care Is Beneficial Both for the Patient and for the Health Service and Should Be Widely Implemented
Stroke 40:1-2, Indredavik,B., 2009
Metabolic Syndrome Clusters and the Risk of Incident Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
Stroke 40:200-205,3, Rodriguez-Colon,S.M.,et al, 2009
Potentially Preventable Strokes in High-Risk Patients with Atrial Fibrillation Who Are Not Adequately Anticoagulated
Stroke 40:235-240,5, Gladstone,D.J.,et al, 2009
Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary Prevention
Stroke 40:213-220, Kettani,F.-Z.,et al, 2009
Association Between Recent Sports Activity, Sports Activity in Young Adulthood, and Stroke
Stroke 40:425-431, Grau,A.J.,et al, 2009
Isolated Nodular Infarction
Stroke 40:487-491, Moon,I.S.,et al, 2009
Serial Diffusion Imaging in a Case of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
Stroke 40:e15-e17, Tzoulis,C. &Bindoff,L.A., 2009
Isolated Lateral Sinus Thrombosis: A Series of 62 Patients
Stroke 40:476-481, Damak,M.,et al, 2009
A Matter of Taste
JNNP 80:139-140, Theys,T.,et al, 2009
Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009
Thrombolytic Therapy for Patients Who Wake-Up With Stroke
Stroke 40:827-832, Barreto,A.D.,et al, 2009
Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
Stroke 40:801-807, Arnold,M.,et al, 2009
Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII?
Stroke 40:833-840, Mayer,S.A.,et al, 2009
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Heart Association
Stroke 40:994-1025, Bederson,J.B.,et al, 2009
Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009
Disappearing Hyperdense Middle Cerebral Artery Sign in Ischaemic Stroke Patients Treated with Intravenous Thrombolysis: Clinical Course and Prognostic Significance
JNNP 80:273-278,248, Kharitonova,T.,et al, 2009
Neurosarcoidosis: A Study of 30 New Cases
JNNP 80:297-304, Joseph,F.G. &Scolding,N.J., 2009